Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 11.5% on Wednesday . The company traded as low as C$0.12 and last traded at C$0.12. 190,035 shares were traded during mid-day trading, a decline of 10% from the average session volume of 212,133 shares. The stock had previously closed at C$0.13.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The company has a market capitalization of C$19.46 million, a price-to-earnings ratio of -3.71 and a beta of 0.39. The company has a 50-day moving average price of C$0.15 and a 200-day moving average price of C$0.12.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- What is Put Option Volume?
- Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?
- How to Capture the Benefits of Dividend Increases
- 3 Small-Cap Stocks With Room to Run Despite Tariff Headwinds
- Most active stocks: Dollar volume vs share volume
- CRSPR Stock Could Be Ready to Deliver on Its Massive Promise
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
